ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.

Matthew C Stubbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.